New crystal form of empagliflozin intermediate and preparation method thereof
The invention provides a novel crystal form of an empagliflozin intermediate, and more particularly provides a novel crystal form of (3S)-3-[4-[(5-bromo-2-chlorphenyl) methyl] phenoxy] tetrahydrofuran and a preparation method thereof, and the novel crystal form is higher in melting point and lower i...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention provides a novel crystal form of an empagliflozin intermediate, and more particularly provides a novel crystal form of (3S)-3-[4-[(5-bromo-2-chlorphenyl) methyl] phenoxy] tetrahydrofuran and a preparation method thereof, and the novel crystal form is higher in melting point and lower in hygroscopicity. The novel crystal form grows in a pressure range suitable for industrial production conditions to form a crystal nucleus, and is prepared through cooling and water-promoted crystallization, the preparation method is simple in reaction and high in operability, and the prepared product is good in quality and high in yield and is a preparation process suitable for industrialization.
本发明提供了一种恩格列净中间体的新晶型,更具体而言,本发明提供了(3S)-3-[4-[(5-溴-2-氯苯基)甲基]苯氧基]四氢呋喃的新晶型及其制备方法,该新晶型熔点更高、引湿性更低。该新晶型在适合工业生产条件下的压力范围内养晶形成晶核,并通过降温和水促析晶制得,制备方法反应简单、可操作性高、制备的产品质量好、收率高,是适合产业化的制备工艺。 |
---|